Appleton Partners Inc. MA Sells 897 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Appleton Partners Inc. MA trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,319 shares of the healthcare conglomerate’s stock after selling 897 shares during the period. UnitedHealth Group comprises 1.0% of Appleton Partners Inc. MA’s holdings, making the stock its 29th biggest holding. Appleton Partners Inc. MA’s holdings in UnitedHealth Group were worth $11,456,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of UNH. Anfield Capital Management LLC bought a new position in UnitedHealth Group in the 2nd quarter worth about $26,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group in the 2nd quarter worth about $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in UnitedHealth Group in the 2nd quarter worth about $28,000. Activest Wealth Management bought a new position in UnitedHealth Group in the 2nd quarter worth about $29,000. Finally, Ten Capital Wealth Advisors LLC grew its stake in UnitedHealth Group by 111.6% in the 2nd quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock worth $36,000 after acquiring an additional 48 shares in the last quarter. Institutional investors own 86.20% of the company’s stock.

Shares of NYSE:UNH traded up $3.03 during midday trading on Thursday, reaching $450.16. The company’s stock had a trading volume of 2,248,836 shares, compared to its average volume of 2,940,181. The firm has a market capitalization of $423.98 billion, a PE ratio of 27.93, a P/E/G ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a twelve month low of $320.35 and a twelve month high of $466.00. The stock has a fifty day moving average of $430.47 and a 200 day moving average of $418.01. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, topping the Zacks’ consensus estimate of $4.41 by $0.11. The firm had revenue of $72.34 billion for the quarter, compared to analyst estimates of $71.24 billion. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.51 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be paid a $1.45 dividend. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.29%. UnitedHealth Group’s payout ratio is currently 35.98%.

A number of equities analysts have commented on UNH shares. Morgan Stanley upped their target price on shares of UnitedHealth Group from $488.00 to $499.00 and gave the stock an “overweight” rating in a research note on Friday, October 15th. SVB Leerink started coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They issued an “outperform” rating and a $480.00 price target for the company. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price target for the company in a research report on Wednesday, October 27th. BMO Capital Markets upped their price target on shares of UnitedHealth Group from $435.00 to $475.00 and gave the stock a “market perform” rating in a research report on Monday, October 18th. Finally, Mizuho upped their price target on shares of UnitedHealth Group from $455.00 to $500.00 and gave the stock a “buy” rating in a research report on Wednesday, November 10th. One analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $477.35.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction on Friday, September 17th. The shares were sold at an average price of $419.00, for a total transaction of $1,047,500.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 75,000 shares of the stock in a transaction on Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. Insiders sold 82,500 shares of company stock worth $36,855,125 in the last quarter. Company insiders own 0.55% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Story: What does a hold rating mean?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.